Table 1 Expression of miR-3622a-3p and SALL4 in human colorectal cancer and the patients’ clinicopathological characteristics.

From: MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4

Characteristics

Number

miR-3622a-3p expression

P-value

SALL4 expression

p-value

High group

Low group

High group

Low group

Age(years)

       

≥60

32

17

15

0.82

18

14

0.494

<60

48

23

25

 

22

26

 

Gender

       

Male

50

24

26

0.818

23

27

0.489

Female

30

16

14

 

17

13

 

Size(cm)

       

≥3(cm)

42

14

28

0.003**

26

16

0.043*

<3(cm)

38

26

12

 

14

24

 

Stage

       

I/II

45

26

19

0.176

21

24

0.652

III/IV

35

14

21

 

19

16

 

T grade

       

T1 + T2

47

25

22

0.65

18

29

0.22

T3 + T4

33

15

18

 

22

11

 

Lymph node metastasis

       

N1–N3

48

18

30

0.012*

29

19

0.039*

N0

32

22

10

 

11

21

 

Histology grade

       

Well-moderately

34

19

15

0.498

13

21

0.113

Poorly-signet

46

21

25

 

27

19

 
  1. *p < 0.05 and **p < 0.01 Statistically significant difference.